The Development of a Multitarget, Multicolor Fluorescence in Situ Hybridization Assay for the Detection of Urothelial Carcinoma in Urine
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 2 (3) , 116-123
- https://doi.org/10.1016/s1525-1578(10)60625-3
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- Fluorescence in Situ Hybridization Identifies More Aggressive Types of Primarily Noninvasive (Stage pTa) Bladder CancerJournal of Urology, 1997
- Clinical Evaluation of Cell Deoxyribonucleic Acid Content Measured by Flow Cytometry in Bladder CancerJournal of Urology, 1996
- Origins and clinical implications of aneuploidy in early bladder cancerCytometry, 1995
- Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: A comparative studyDiagnostic Cytopathology, 1995
- The clinical value of urinary cytology: 12 years of experience with 615 patients.Journal of Clinical Pathology, 1995
- Identification of H-ras Mutations in Urine Sediments Complements Cytology in the Detection of Bladder TumorsJNCI Journal of the National Cancer Institute, 1995
- Detection of Genetic Aberrations in Bladder Cancer Using in Situ HybridizationAnnals of the New York Academy of Sciences, 1993
- Intratumoral Heterogeneity in DNA Ploidy of Bladder CarcinomasOncology, 1992